Pharmafile Logo

Value communications

- PMLiVE

What do HCPs want from pharma medical information sites in 2026?

At Graphite, we regularly carry out first-hand research with healthcare professionals (HCPs) to understand how they interact with digital experiences in practice. When you combine those conversations with wider sector...

Graphite Digital

- PMLiVE

Bridging the value gap: The systems, teams and mindsets that matter

In pharma, the challenge is no longer understanding what HCPs want from digital. It’s delivering it consistently. In this webinar, we explored what needs to change inside organisations to make...

Graphite Digital

- PMLiVE

GSK announces bepirovirsen’s ‘functional cure’ data to treat chronic hepatitis B

Over 240 million people worldwide live with chronic hepatitis B

- PMLiVE

The blind spot undermining pharma product launches – and how to eliminate it

Something critical is missing: a clear view of what’s actually happening on the ground

- PMLiVE

Delphia Therapeutics appoints David Kerstein as Chief Medical Officer

Kerstein was most recently CMO of IDRx, a company acquired by GSK in 2025

- PMLiVE

NICE recommends Genmab’s Tivdak for recurrent or metastatic cervical cancer

It is estimated that 3,300 women are diagnosed with cervical cancer in the UK each year

- PMLiVE

Closing the last mile: translating national market access into real-world patient access in the UK

UK market access needs the right conditions nationally, along with subnational investment and delivery locally

- PMLiVE

The Ripple Effect: Why Connection is the Heart of Healthcare Leadership

In the fast-paced environment of clinical medicine, it is easy to focus solely on data and outcomes. However, as Dr. Toyin Nwafor (Gilead Sciences) and Dr. Shirin Mazumder (University of...

Medscape Education

- PMLiVE

Why HCP AI use is now a brand strategy opportunity for pharma

For pharma brands, AI visibility is no longer just a digital question, it is fast becoming a brand strategy imperative

- PMLiVE

The hidden work of turning breakthroughs into outcomes

The “problem” in healthcare comms is rarely what you say, it’s whether people can act on it. This article explains how we design whole-person engagement to turn intent into sustained...

Mednet

- PMLiVE

PMEA welcome Simon Bates as new Chair of the judging panel

Roche and Alnylam share their experiences entering the PMEAs

- PMLiVE

Lilly to acquire LimmaTech Biologics and Vaccine Company in deals totalling $2.33bn

The acquisitions reinforce the company’s commitment to reduce the long-term burden of serious disease

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links